Dr John spreading the message (still), page-17

I just wonder whether there is a bigger game than a distribution deal. I've been thinking that a distribution deal could be done pretty quickly even at this stage of the clinical trials.

But in my view, the only real reason for the a delay this long is if something much bigger is the pipeline, like a sale of the company lock, stock and barrel.

Until recently I've wanted this company to stay in Aussie hands (especially in my own hands!) but now I think the bigger picture looks like the work is being done to sell.

Maybe a sale also supports the steady accumulation we've seen recently?